Skip to main content
  • About
    • Our Mission
    • Threat of AMR
    • Access and Appropriate Use Principles
    • Our Investors
  • Team
  • Investments
    • How We Invest
    • Our Portfolio
    • Get On Our Radar
  • News
  • Connect

Posts by admin:

  • All
  • In the News
  • Press Releases
  • Media
  • Fund Resources
October 26, 2026
In the News

WSJ: Proposed U.S. Restrictions Could Reshape Biotech Investment in China

Read More +
October 23, 2026
In the News

Harvard Medical School's Bioethics Blog: The ethics of the last antibiotic

Read More +
October 20, 2026

Forbes Q&A: AI Can't Solve the Antibiotic Crisis

Read More +
September 30, 2026
In the News

Op-Ed: AMR is a Growing Threat to the Elderly

Read More +
September 29, 2026
In the News

Withdrawal of Approved Antibiotic in U.S. Renews Questions About Market Sustainability

Read More +
September 11, 2026
In the News

A Comparative Review of Implemented and Emerging Pull Incentives

Read More +
August 13, 2026
In the News

Commentary: Fix the Market Challenges Behind Microbiome-Sparing Antibiotics

Read More +
August 6, 2026
In the News

Vedanta Biosciences Secures New Funding to Advance Phase 3 Program

Read More +
Previous page Next page
contact-bg-img

Connect With Us

Contact
AMR Action Fund Footer Logo

Enabling
Breakthroughs in
Antimicrobials

Stay connected

Stay up-to-date on our work to bring 2 to 4 new antibiotics to patients by the end of the decade. When we have news, we will let you know.

  • About
  • Team
  • Latest
  • Threat of AMR
  • Connect
  • Investments
  • Japan Disclaimer
  • Privacy Policy